seed
Stage
About
Alphabiome develops AI technology that reads raw, unannotated genetic sequencing data across multiple organisms to predict patient responses to therapies, enabling faster and more precise drug development.
Explore Alphabiome's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.